Salarius Pharmaceuticals Shares Halted To The Downside; Stock Now Up 23.26%
Portfolio Pulse from Benzinga Newsdesk
Salarius Pharmaceuticals experienced a trading halt due to a significant downside movement, but the stock has since rebounded and is now up by 23.26%.
October 15, 2024 | 4:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Salarius Pharmaceuticals' stock was halted due to a downside movement but has since increased by 23.26%, indicating a volatile trading session.
The trading halt suggests significant volatility, but the subsequent 23.26% increase indicates a positive recovery. This could attract short-term traders looking to capitalize on the volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100